Pro Dex Inc (PDEX) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2026, Pro Dex reported revenue of $77.5M, up 16.5% from $66.6M the year before. Net income was $13.7M (a 17.6% net margin), or $4.12 per diluted share. Gross margin was 31.4% and operating margin was 16.8%. Operating activities generated $7.2M of cash, leaving $6.8M of free cash flow. At fiscal year end, Pro Dex held $74.5M in total assets against $26.9M in total liabilities, including $8.2M of cash and equivalents.
Open the full interactive Pro Dex financials → Quarterly statements, key ratios, valuation history and price charts.
Pro Dex Key Stats
| Share Price | $62.27 |
|---|---|
| Market Cap | $206.6M |
| P/E Ratio | 15.1 |
| Revenue YoY Growth | +16.4% |
| 52-Week Range | $23.91 – $73.41 |
| Shares Outstanding | 3.2 million (basic, 2026 Q4) |
Pro Dex Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $38.0M | $42.0M | $46.1M | $53.8M | $66.6M | $77.5M |
| Gross Profit | $13.6M | $13.1M | $12.7M | $14.6M | $19.5M | $24.3M |
| Operating Income | $4.5M | $5.1M | $5.8M | $7.2M | $10.7M | $13.0M |
| Pre-Tax Income | $5.6M | $4.7M | $9.4M | $2.6M | $12.1M | $18.0M |
| Income Tax | $1.2M | $851,000 | $2.4M | $507,000 | $3.1M | $4.4M |
| Net Income | $4.5M | $3.9M | $7.1M | $2.1M | $9.0M | $13.7M |
| Diluted EPS | $1.13 | $1.02 | $1.95 | $0.60 | $2.67 | $4.12 |
Pro Dex Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $18.5M | $18.7M | $19.9M | $20.4M |
| Net Income | $4.7M | $2.2M | $3.9M | $2.9M |
| Diluted EPS | $1.40 | $0.66 | $1.20 | $0.86 |
Pro Dex Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.7M | $849,000 | $2.9M | $2.6M | $419,000 | $8.2M |
| Current Assets | $25.0M | $31.2M | $31.0M | $36.6M | $47.3M | $53.2M |
| Total Assets | $40.3M | $47.3M | $51.8M | $52.5M | $61.2M | $74.5M |
| Current Liabilities | $5.9M | $11.4M | $9.7M | $12.9M | $14.6M | $13.0M |
| Total Long-Term Debt | $12.8M | $13.6M | $12.8M | $12.0M | $15.4M | $17.5M |
| Total Liabilities | $20.2M | $23.7M | $20.2M | $21.6M | $24.6M | $26.9M |
| Shareholders' Equity | $20.1M | $23.7M | $31.6M | $30.9M | $36.6M | $47.6M |
Pro Dex Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$2.1M | -$847,000 | $5.5M | $6.2M | -$1.7M | $7.2M |
| Cash From Investing | -$3.7M | -$1.2M | -$885,000 | -$2.2M | -$238,000 | $3.9M |
| Cash From Financing | $3.1M | -$790,000 | -$2.5M | -$4.3M | -$292,000 | -$3.4M |
| Free Cash Flow | -$3.8M | -$2.5M | — | — | — | $6.8M |
Figures from Pro Dex's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Pro Dex financials page for every line item.
Pro Dex Company Profile
| Ticker | PDEX |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Irvine, California |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000788920 |
Frequently Asked Questions
What was Pro Dex's revenue in fiscal 2026?
Pro Dex (PDEX) reported revenue of $77.5M for fiscal 2026.
What is Pro Dex's annual revenue history?
Pro Dex's annual revenue by fiscal year: 2021: $38.0M; 2022: $42.0M; 2023: $46.1M; 2024: $53.8M; 2025: $66.6M; 2026: $77.5M.
What was Pro Dex's net income in fiscal 2026?
Pro Dex reported net income of $13.7M for fiscal 2026.
What was Pro Dex's earnings per share (EPS) in fiscal 2026?
Pro Dex's diluted EPS was $4.12 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Pro Dex generate in fiscal 2026?
Pro Dex generated $6.8M of free cash flow in fiscal 2026.
What was Pro Dex's revenue last quarter?
In its most recent reported quarter (2026 Q4), Pro Dex reported revenue of $20.4M.
How much debt does Pro Dex have?
Pro Dex reported $17.5M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Pro Dex are outstanding?
Pro Dex reported a weighted average of 3.2 million basic shares outstanding in 2026 Q4.
What is Pro Dex's market cap?
Based on its latest closing price, Pro Dex (PDEX) has a market capitalization of about $206.6M.
When does Pro Dex's fiscal year end?
Pro Dex's fiscal year end, as registered with the SEC, is June 30.
Where is Pro Dex headquartered?
Pro Dex lists its business address in Irvine, California in its SEC filings.
Pro Dex Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →